Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Curran

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cellsKim R Simpfendorfer, Brandon E Armstead, Andrew Shih, et al.
Brain, Behavior, and Immunity|July 6, 2017
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's diseaseYu Sun, Dai Wang, Giacomo Salvadore, et al.
Journal of Crohn'S & Colitis|March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's DiseaseMatthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Nature Communications|July 25, 2022
Sunlight-driven nitrate loss records Antarctic surface mass balancePete D Akers, Joël Savarino, Nicolas Caillon, et al.
Clinical and Translational Gastroenterology|June 24, 2016
Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association LociAntonio F Di Narzo, Lauren A Peters, Carmen Argmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16pJochen Hampe, Henning Frenzel, Muddassar M Mirza, et al.
Communications Biology|January 24, 2023
A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patientsLauren A Peters, Joshua R Friedman, Aleksandar Stojmirovic, et al.
Plos One|March 2, 2023
Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot studyVivek A Rudrapatna, Yao-Wen Cheng, Colin Feuille, et al.
Gastroenterology|July 8, 2018
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative ColitisShannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Precision MedicineLee A Denson, Mark Curran, Dermot P B McGovern, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2015
Autoimmune disease-associated haplotypes of BLK exhibit lowered thresholds for B cell activation and expansion of Ig class-switched B cellsKim R Simpfendorfer, Brandon E Armstead, Andrew Shih, et al.
Brain, Behavior, and Immunity|July 6, 2017
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's diseaseYu Sun, Dai Wang, Giacomo Salvadore, et al.
Journal of Crohn'S & Colitis|March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's DiseaseMatthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Nature Communications|July 25, 2022
Sunlight-driven nitrate loss records Antarctic surface mass balancePete D Akers, Joël Savarino, Nicolas Caillon, et al.
Clinical and Translational Gastroenterology|June 24, 2016
Blood and Intestine eQTLs from an Anti-TNF-Resistant Crohn's Disease Cohort Inform IBD Genetic Association LociAntonio F Di Narzo, Lauren A Peters, Carmen Argmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16pJochen Hampe, Henning Frenzel, Muddassar M Mirza, et al.
Communications Biology|January 24, 2023
A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patientsLauren A Peters, Joshua R Friedman, Aleksandar Stojmirovic, et al.
Plos One|March 2, 2023
Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot studyVivek A Rudrapatna, Yao-Wen Cheng, Colin Feuille, et al.
Gastroenterology|July 8, 2018
Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative ColitisShannon E Telesco, Carrie Brodmerkel, Hongyan Zhang, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Precision MedicineLee A Denson, Mark Curran, Dermot P B McGovern, et al.
Pageof 3